Mounjaro (tirzepatide) Update

From 23 June 2025, following approval by NICE, tirzepatide (Mounjaro®) will be available in the NHS for eligible patients who meet the strict, nationally-set, criteria. The current criteria is that patients are those with a BMI of 40 or higher, and with four or more of the qualifying comorbidities (hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular […]